Immunogen (NASDAQ: IMGN) to Resume Trading at 8 a.m. Following News of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Immunogen (IMGN) shares surge on news of takeover by AbbVie (ABBV)November 30, 2023 9:09 AM Sutro Biopharma (STRO) Trades Higher in Sympathy with Immunogen (IMGN)November 30, 2023 7:45 AM AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $31.26 Per Share, $10.1 BillionNovember 30, 2023 7:31 AM AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor PortfolioNovember 30, 2023 7:30 AM